On March 4, the innovative drug sector experienced a partial rebound in the afternoon session. Jiangsu Yahong Meditech Co.,Ltd. surged by 20%, hitting the daily limit. Allist Pharmaceuticals rose more than 10%, while Rundo Pharmaceuticals, Olipop Biological, ChemPartner Pharmatech, and Shouyao Holdings also followed with gains.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.